Alzheimer's soluble amyloid beta is a normal component of human urine

FEBS Lett. 1997 May 12;408(1):105-8. doi: 10.1016/s0014-5793(97)00400-6.

Abstract

Soluble A beta (Sa beta) is normally present at a low concentration in human plasma and cerebrospinal fluid. Although the factors involved in the regulation of Sa beta plasma levels are still unknown, we have explored its excretion in the urine as one of the possible homeostatic mechanisms. The presence of Sa beta in the urine was investigated via immunoprecipitation experiments with anti-A beta antibodies followed by detection and identification by immunoblot, MALDI mass spectrometry and sequence analysis. Soluble A beta (4.3 kDa) immunoreactivity was present in the urine of normal donors, Down's syndrome individuals as well as in patients with renal disorders exhibiting glomerular or mixed proteinuria. Edman degradation of the immunoprecipitated material yielded the intact A beta N-terminus and mass spectra analysis indicated the existence of a major component at mlz 4327, corresponding to the molecular mass of A beta1-40. Semiquantitative data obtained from the immunoprecipitation experiments indicate that under normal conditions the daily excretion of intact Sa beta in the urine represents less than 1% of the circulating pool.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / immunology
  • Amyloid beta-Peptides / urine*
  • Antibodies, Monoclonal / immunology
  • Blotting, Western
  • Down Syndrome / urine
  • Humans
  • Kidney Diseases / urine
  • Molecular Weight
  • Peptide Fragments / urine
  • Precipitin Tests
  • Proteinuria / urine
  • Solubility
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal
  • Peptide Fragments